Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug.

Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug.
复制标题

DOI:
10.3390/ijms22062828
复制
发表时间:
2021-03-11
影响因子:
5.6
通讯作者:
Tarnowski M
Tarnowski M
中科院分区:
生物学2区
文献类型:
--
作者:
Kopytko P;Piotrowska K;Janisiak J;Tarnowski M

文献摘要

参考文献

被引文献

相似文献

从藤黄果皮和叶子中提取的藤黄醇是一种聚异戊烯基二苯甲酮。在传统医学中,它因其抗氧化和抗炎特性而被使用。多项研究表明,在癌细胞系和实验动物模型中,garcinol具有抗癌作用。Garcinol在癌细胞中的作用基于其抗氧化和抗炎特性,但也基于其抑制组蛋白乙酰转移酶(HATs)的效力。最近的研究表明,garcinol也可能解除参与肿瘤发生和进展的mirna的表达。本文重点介绍了garcinol作为HAT抑制剂和miRNA调节因子在各种癌症发生发展中的最新研究进展。Garcinol可能被认为是下一代表观遗传药物的候选药物,但需要进一步的研究来确定确切的毒性、剂量、给药途径和对患者的安全性。
Garcinol extracted from Garcinia indica fruit peel and leaves is a polyisoprenylated benzophenone. In traditional medicine it was used for its antioxidant and anti-inflammatory properties. Several studies have shown anti-cancer properties of garcinol in cancer cell lines and experimental animal models. Garcinol action in cancer cells is based on its antioxidant and anti-inflammatory properties, but also on its potency to inhibit histone acetyltransferases (HATs). Recent studies indicate that garcinol may also deregulate expression of miRNAs involved in tumour development and progression. This paper focuses on the latest research concerning garcinol as a HAT inhibitor and miRNA deregulator in the development and progression of various cancers. Garcinol may be considered as a candidate for next generation epigenetic drugs, but further studies are needed to establish the precise toxicity, dosages, routes of administration, and safety for patients.
DOI: 10.1038/nature24028
发表时间: 2017-10-05
期刊: Nature
影响因子: 64.8
作者:
Lasko LM;Jakob CG;Edalji RP;Qiu W;Montgomery D;Digiammarino EL;Hansen TM;Risi RM;Frey R;Manaves V;Shaw B;Algire M;Hessler P;Lam LT;Uziel T;Faivre E;Ferguson D;Buchanan FG;Martin RL;Torrent M;Chiang GG;Karukurichi K;Langston JW;Weinert BT;Choudhary C;de Vries P;Van Drie JH;McElligott D;Kesicki E;Marmorstein R;Sun C;Cole PA;Rosenberg SH;Michaelides MR;Lai A;Bromberg KD
通讯作者: Bromberg KD
DOI: 10.1101/gad.1787609
发表时间: 2009-04-01
影响因子: 10.5
作者:
Berger, Shelley L.;Kouzarides, Tony;Shilatifard, Ali
通讯作者: Shilatifard, Ali
13,14-二羟基对于藤黄醇的抗癌作用至关重要
DOI: 10.1016/j.bioorg.2015.04.010
发表时间: 2015-06-01
影响因子: 5.1
作者:
Han, Chao-Ming;Zhou, Xin-Ying;Chen, Xin
通讯作者: Chen, Xin
DOI: 10.3390/ijms20040800
发表时间: 2019-02-02
影响因子: 5.6
作者:
Farhan, Mohd;Malik, Arshi;Ahmad, Aamir
通讯作者: Ahmad, Aamir
CapG 通过 PIK3R1/P50 反式激活促进乳腺癌对紫杉醇的耐药性
DOI: 10.7150/thno.36338
发表时间: 2019-01-01
期刊: THERANOSTICS
影响因子: 12.4
作者:
Chi, Yayun;Xue, Jingyan;Wu, Jiong
通讯作者: Wu, Jiong